Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats

BACKGROUND: Astragaloside IV (AS-IV) was reported to play a role in improving diabetic nephropathy (DN), however, the underlying mechanisms still remain unclear. The aim of the present study is to investigate whether AS-IV ameliorates DN via the regulation of endothelial nitric oxide synthase (eNOS)...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:BMC Complement Altern Med
Main Authors: Fan, Yuyan, Fan, Hongyu, Zhu, Bin, Zhou, Yilun, Liu, Qingshan, Li, Ping
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6896771/
https://ncbi.nlm.nih.gov/pubmed/31805910
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12906-019-2728-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados